Addus Homecare Corp Stock Price, News & Analysis

Addus HomeCare (Nasdaq: ADUS), a home care services provider, announced its participation in the Jefferies 2025 Healthcare Services Conference in Nashville, Tennessee. The company's Chairman and CEO Dirk Allison, along with CFO Brian Poff, will engage in a fireside chat during the conference scheduled for September 29-30, 2025.

The presentation will be broadcast live on September 30, 2025, at 10:20 AM ET and will be accessible through the Investor Relations section of Addus's website. A replay option will be available for one month after the presentation.

Addus HomeCare (NASDAQ: ADUS) has appointed Heather Dixon as its new President and Chief Operating Officer, effective mid-September 2025. Dixon, who currently serves as an independent director for Addus, will resign from the board to assume her new executive role.

Dixon brings extensive healthcare leadership experience, most recently serving as CFO of Acadia Healthcare, and previously held executive positions at Everside Health, Walgreens Boots Alliance, and Aetna. The current President and COO, W. Bradley Bickham, will transition to an advisor role to the CEO until his planned retirement in March 2026.

The appointment represents a strategic leadership transition for Addus HomeCare, with Dixon's operational and financial management expertise expected to drive the company's next growth phase.

Addus HomeCare (NASDAQ: ADUS) reported strong Q2 2025 financial results, with net service revenues increasing 21.8% to $349.4 million. The company achieved net income of $22.1 million, or $1.20 per diluted share, and adjusted EBITDA grew 24.5% to $43.9 million.

The company's personal care segment, representing 77% of business, showed 7.4% organic revenue growth. Hospice care (17.8% of business) delivered 10% organic growth, while home health services accounted for 5.2% of revenue.

Notably, Addus acquired Helping Hands Home Care for $21.3 million on August 1, 2025, expanding its Pennsylvania operations. The acquisition adds approximately $16.7 million in annualized revenues and over 500 employees serving about 600 patients daily.

Addus HomeCare (Nasdaq: ADUS), a home care services provider, has scheduled its second quarter 2025 earnings release for Monday, August 4, 2025, after market close. The company will host a conference call on Tuesday, August 5, 2025, at 9:00 a.m. Eastern Time.

Key executives participating in the call include Chairman and CEO Dirk Allison, EVP and CFO Brian Poff, and President and COO Brad Bickham. Investors can access the call via phone or listen to the live broadcast on the company's website, with replay options available through August 12, 2025.

Addus HomeCare (ADUS) announced significant rate increases for in-home care services in Illinois and Texas. Illinois approved a 3.9% increase to $30.80 per hour effective January 1, 2026, expected to generate $17.5 million in annualized revenue with margins in low 20%s. Texas approved a larger 9.9% increase to $17.13 per hour effective September 1, 2025, projected to add $17.7 million in annualized revenue with margins just over 20%. The increases will support minimum wage requirements for care workers and affect multiple state healthcare programs. Illinois represents ADUS's largest personal care market, while Texas recently became their second-largest following the Gentiva acquisition. Both rate increases are subject to federal approval.

Addus HomeCare Corporation (ADUS), a home care services provider, has announced its participation in two major investor conferences in May 2025:

1. The BofA Securities 2025 Health Care Conference in Las Vegas on May 14, where Chairman and CEO Dirk Allison, President and COO Brad Bickham, and EVP/CFO Brian Poff will present at 11:20 AM CT.

2. The 2025 RBC Capital Markets Global Healthcare Conference in New York on May 20, featuring presentations by Dirk Allison and Brian Poff at 7:30 AM CT.

Both presentations will be available for live broadcast and replay on the company's website (www.addus.com) under the Investor Relations section, with replays accessible for one month after the events.

Addus HomeCare (NASDAQ: ADUS) reported strong Q1 2025 financial results with net service revenues increasing 20.3% to $337.7 million. Net income reached $21.2 million ($1.16 per diluted share), while adjusted net income was $26.0 million ($1.42 per diluted share). The company's personal care segment, representing 76.5% of business, drove growth with a 7.4% organic revenue increase. The hospice care segment (18.2% of business) showed 9.9% organic growth, while home health services accounted for 5.3% of revenue. The results include the first full quarter of Gentiva's personal care operations, acquired in December 2024. The company maintains a strong financial position with $97.0 million in cash and $203.0 million in bank debt, with significant credit facility availability of $421.9 million.

Addus HomeCare (Nasdaq: ADUS) has scheduled its first quarter 2025 earnings release and conference call. The company will release its financial results for Q1 2025 on Monday, May 5, 2025, after market close.

A conference call will be held on Tuesday, May 6, 2025, at 9:00 a.m. Eastern Time, featuring key executives including Chairman and CEO Dirk Allison, CFO Brian Poff, and President and COO Brad Bickham. Investors can join via phone at (833) 629-0620 (US) or (412) 317-1805 (international).

A replay will be available until May 13, 2025, through (877) 344-7529 (US) or (412) 317-0088 (international) using pass code 3473942. The call will also be broadcast live on the company's website with a one-month replay available.

Addus HomeCare (ADUS) has announced significant leadership changes. W. Bradley Bickham, President and Chief Operating Officer, will retire in March 2026 after eight years with the company. The announcement includes a planned transition period of approximately one year to identify and develop new leadership.

Additionally, the Board of Directors has approved an Amended and Restated Employment Agreement with Chairman and CEO Dirk Allison, extending his term for three additional years through March 2028. This leadership continuity aims to support the company's ongoing growth strategy and maintain its patient-focused culture.